Cargando…

Incident Type 2 Diabetes Risk of Selective Estrogen Receptor Modulators in Female Patients with Breast Cancer

Accumulating evidence indicates a link between diabetes and cancer. Selective estrogen receptor modulators (SERMs) may increase diabetes risk via antiestrogen effects. This study investigated incident diabetes risk of SERM treatment and its effects on metastatic cancer and death prevention in breast...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choi, Yeo-Jin, Bak, Keunhyeong, Yeo, Yoon, Choi, Yongwon, Shin, Sooyoung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8472249/ https://www.ncbi.nlm.nih.gov/pubmed/34577625 http://dx.doi.org/10.3390/ph14090925

Ejemplares similares

Impact of metformin on statin‐associated myopathy risks in dyslipidemia patients
por: Bak, Keunhyeong, et al.
Publicado: (2023)

Incident cancer risk in dipeptidyl peptidase-4 inhibitor-treated patients with type 2 diabetes mellitus
por: Choi, Yeo Jin, et al.
Publicado: (2019)

Incident infection risks depending on oral antidiabetic exposure in insulin-treated type 2 diabetes patients
por: Park, Sanghwa, et al.
Publicado: (2023)

Impact of a Ketogenic Diet on Metabolic Parameters in Patients with Obesity or Overweight and with or without Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials
por: Choi, Yeo Jin, et al.
Publicado: (2020)

Breast-related effects of selective estrogen receptor modulators and tissue-selective estrogen complexes
por: Smith, Carolyn L, et al.
Publicado: (2014)

Estrogen receptor transcription and transactivation: Estrogen receptor alpha and estrogen receptor beta - regulation by selective estrogen receptor modulators and importance in breast cancer
por: S Katzenellenbogen, Benita, et al.
Publicado: (2000)

Selective Estrogen Receptor Modulators
por: An, Ki-Chan
Publicado: (2016)

The Effect of Selective Estrogen Receptor Modulators (SERMs) on the Tamoxifen Resistant Breast Cancer Cells
por: Chang, Bo Yoon, et al.
Publicado: (2011)

Safety Assessment on Serious Adverse Events of Targeted Therapeutic Agents Prescribed for RAS Wild-Type Metastatic Colorectal Cancer: Systematic Review and Network Meta-Analysis
por: Choi, Yeo Jin, et al.
Publicado: (2022)

Incidence and Risk of Venous Thromboembolism in Bisphosphonates and Selective Estrogen Receptor Modulators Treatment in Korea
por: Park, So Young, et al.
Publicado: (2021)

New Evidence of Potential Benefits of Dexamethasone and Added on Therapy of Fludrocortisone on Clinical Outcomes of Corticosteroid in Sepsis Patients: A Systematic Review and Meta-Analysis
por: Son, Ji-young, et al.
Publicado: (2021)

Cardiometabolic Effects of Endocrine Treatment of Estrogen Receptor–Positive Early Breast Cancer
por: Cheung, Yee-Ming, et al.
Publicado: (2019)

Meta-Analysis of Drug Delivery Approaches for Treating Intracellular Infections
por: Shin, Sooyoung, et al.
Publicado: (2022)

Selective Estrogen Receptor Down-Regulator and Selective Estrogen Receptor Modulators Differentially Regulate Lactotroph Proliferation
por: Kansra, Sanjay, et al.
Publicado: (2010)

A nationwide pharmacovigilance investigation on trends and seriousness of adverse events induced by anti-obesity medication
por: Choi, Yeo Jin, et al.
Publicado: (2023)

Selective estrogen receptor modulators in the prevention of breast cancer in premenopausal women: a review
por: Oceguera-Basurto, Paola, et al.
Publicado: (2020)

New Selective Estrogen Receptor Modulators (SERMs) in Development
por: Silverman, Stuart L.
Publicado: (2010)

The evolution of selective estrogen receptor modulators in osteoporosis therapy
por: Hadji, P.
Publicado: (2012)

Advances in the Development of Prodrugs as Selective Modulators of Estrogen Receptors
por: Pollock, Julie A, et al.
Publicado: (2022)

Estrogens, selective estrogen receptor modulators, and a selective estrogen receptor down-regulator inhibit endothelial production of tissue factor pathway inhibitor 1
por: Dahm, Anders EA, et al.
Publicado: (2006)

Estrogen and Estrogen Receptor Modulators: Potential Therapeutic Strategies for COVID-19 and Breast Cancer
por: Hu, Shuying, et al.
Publicado: (2022)

Dax1 modulates ERα-dependent hypothalamic estrogen sensing in female mice
por: Ramos-Pittol, Jose M., et al.
Publicado: (2023)

Update on bazedoxifene: A novel selective estrogen receptor modulator
por: Biskobing, Diane M
Publicado: (2007)

Selective estrogen receptor modulators: tissue specificity and clinical utility
por: Martinkovich, Stephen, et al.
Publicado: (2014)

Translational Significance of Selective Estrogen Receptor Modulators in Psychiatric Disorders
por: Khan, Mohammad M.
Publicado: (2018)

Novel Selective Estrogen Receptor Modulator Ameliorates Murine Colitis
por: Polari, Lauri, et al.
Publicado: (2019)

Add-On Selective Estrogen Receptor Modulators for Methadone Maintenance Treatment
por: Huang, Chieh-Liang, et al.
Publicado: (2021)

Combination of selective androgen and estrogen receptor modulators in orchiectomized rats
por: Roch, P. J., et al.
Publicado: (2022)

Bazedoxifene, a Selective Estrogen Receptor Modulator, Promotes Functional Recovery in a Spinal Cord Injury Rat Model
por: Kim, Yiyoung, et al.
Publicado: (2021)

Selective estrogen receptor modulator with estrogen does not affect the proliferation and apoptosis of uterine leiomyoma cells
por: Lv, Shu-Lan, et al.
Publicado: (2020)

Factors Influencing Skin Aging and the Important Role of Estrogens and Selective Estrogen Receptor Modulators (SERMs)
por: Lephart, Edwin D, et al.
Publicado: (2022)

Clinical Benefits of Oral Anticoagulant Use in Cancer Patients at Increased Risk for Venous Thromboembolism per Khorana Index
por: Choi, Yeo Jin, et al.
Publicado: (2021)

Progesterone receptor modulates estrogen receptor-α action in breast cancer
por: Mohammed, Hisham, et al.
Publicado: (2015)

Facial Sadness Recognition is Modulated by Estrogen Receptor Gene Polymorphisms in Healthy Females
por: Gutiérrez-Muñoz, Mayra, et al.
Publicado: (2018)

Estrogen receptor coregulator binding modulators (ERXs) effectively target estrogen receptor positive human breast cancers
por: Raj, Ganesh V, et al.
Publicado: (2017)

Pharmacogenomic–pharmacokinetic study of selective estrogen-receptor modulators with intra-patient dose escalation in breast cancer
por: Ishiguro, Hiroshi, et al.
Publicado: (2019)

ELF5 modulates the estrogen receptor cistrome in breast cancer
por: Piggin, Catherine L., et al.
Publicado: (2020)

Genome-wide transcriptional regulation of estrogen receptor targets in fallopian tube cells and the role of selective estrogen receptor modulators
por: Moyle-Heyrman, Georgette, et al.
Publicado: (2016)

Cardioprotective Effect of Selective Estrogen Receptor Modulator Raloxifene Are Mediated by Heme Oxygenase in Estrogen-Deficient Rat
por: Posa, Anikó, et al.
Publicado: (2017)

A Systematic Study of the Impact of Estrogens and Selective Estrogen Receptor Modulators on Prostate Cancer Cell Proliferation
por: Lafront, Camille, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_e9iomff7vpnpgv4qfe22chec8g